OR51E2 and neoplasm: Finally, our recent publication [23] demonstrated the involvement of ORs in tumor progression: we showed, for the first time, that the PSGR (Prostate Specific G protein-coupled Receptor, also named OR51E2), an OR endogenously expressed in LNCaP prostate cancer cells, promotes cell invasiveness in vitro and metatasis emergence in vivo.